CONVERTED PAPER & PAPERBOARD PRODS (NO CONTANERS/BOXES)
Kimberly-Clark Corp.
KMB
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
Last trade$108.71
Day change-$2.63 (-2.36%)
Day range$108.38 – $111.28
Volume2,801,517
Market cap$68.33B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$68.33B
Price / earnings
20.69×
Price / book
23.3×
Price / sales
4.12×
EV / sales
4.4×
EV / EBITDA
23.52×
Profitability
Earnings per share
$5.38
Return on assets
18.64%
Return on equity
112.62%
Dividend yield
2.47%
Liquidity and leverage
Debt / equity
2.21×
Current ratio
0.89×
Quick ratio
0.65×
Cash ratio
0.28×
Cash flow
Price / cash flow
20.21×
Price / free cash flow
35.15×
Free cash flow
$1.94B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for KMB, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$4.13B
$4.19B
$4.16B
$4.08B
$4.15B
$4.16B
$4.05B
$4.1B
Cost of revenue
$2.69B
$2.59B
$2.63B
$2.62B
$2.66B
$2.71B
$2.55B
$2.66B
Gross profit
$1.44B
$1.6B
$1.53B
$1.47B
$1.49B
$1.46B
$1.51B
$1.45B
Selling, general and administrative
$912M
$1B
$920M
$955M
$855M
$863M
$855M
$1.01B
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$925M
$970M
$781M
$999M
$872M
$864M
$878M
$665M
Operating income
$516M
$633M
$753M
$466M
$621M
$592M
$631M
$780M
Interest expense
-$48M
-$53M
-$58M
-$60M
-$65M
-$67M
-$64M
-$64M
Income before taxes
$500M
$627M
$685M
$436M
$592M
$560M
$557M
$352M
Income taxes
$95M
$217M
$164M
$104M
$248M
$116M
$131M
$47M
Net income
$1.8B
$350M
$675M
$510M
$454M
$512M
$573M
$452M
Net income attributable to common shareholders
$1.79B
$345M
$665M
$499M
$446M
$509M
$567M
$447M
EBITDA
$700M
$800M
$946M
$655M
$797M
$814M
$849M
$1.09B
Basic earnings per share
$5.39
$1.04
$2.00
$1.50
$1.34
$1.53
$1.71
$1.34
Diluted earnings per share
$5.37
$1.04
$2.00
$1.50
$1.34
$1.53
$1.70
$1.34
Recent news
Company coverage with links to the original publishers.
The article compares Hershey and Kimberly-Clark as consumer staples investments for 2027. While Kimberly-Clark trades at a lower forward P/E ratio (16.3x vs 20.2x) and offers a higher dividend yield (4.6% vs 3.3%), the author recommends Hershey for its stronger balance sheet, better acquisition integration track record, and growth potential in salty snacks and international markets. Kimberly-Clark's significant debt from its $49 billion Kenvue acquisition presents both risk and upside potential.
Zacks identifies two consumer staples stocks with positive Earnings Surprise Prediction (ESP) metrics that could potentially beat upcoming earnings expectations. General Mills (GIS) has a +0.94% ESP ahead of its December 16, 2026 earnings report, while Kimberly-Clark (KMB) shows a +0.56% ESP before reporting on January 26, 2027. Both stocks hold a Zacks Rank #3 (Hold) rating.
Colgate-Palmolive and Kimberly-Clark are both Dividend Kings with strong track records, but they differ in valuation and growth strategy. Colgate-Palmolive trades at a premium (24.3x forward P/E) with growth driven by its Hill's Pet Nutrition segment, while Kimberly-Clark offers a lower valuation (14.7x forward P/E) but faces integration challenges from its Kenvue acquisition. The choice depends on whether investors believe in Colgate's pet food expansion or Kimberly-Clark's expanded hygiene portfolio.
The article identifies Coca-Cola, Procter & Gamble, and Kimberly-Clark as consumer staple companies that align with Warren Buffett's investment philosophy of buying and holding quality businesses with strong pricing power, steady cash flow, and consistent dividend growth. All three are Dividend Kings with reliable earnings despite challenging consumer markets, though valuations and risk profiles vary.
The Consumer Products-Staples industry faces significant headwinds from elevated cost pressures, consumer price sensitivity, and currency fluctuations. Despite these challenges, four key companies are leveraging operational efficiencies and strategic initiatives to navigate the difficult environment. The industry carries a Zacks Industry Rank #194 (bottom 21%), reflecting negative earnings outlooks, though it has outperformed the S&P 500 over the past year.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$1.28 per share
Declared
Nov 11, 2026
Ex-dividend
Dec 4, 2026
Pay date
Jan 5, 2027
Ex-dividend
Amount / share
Pay date
Type
Sep 4, 2026
$1.28
Oct 2, 2026
recurring
Jun 5, 2026
$1.28
Jul 2, 2026
recurring
Mar 6, 2026
$1.28
Apr 2, 2026
recurring
Dec 5, 2025
$1.26
Jan 5, 2026
recurring
Sep 5, 2025
$1.26
Oct 2, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.